ASH 2012 Interviews Part 3 Dr. John Byrd on Ib... - CLL Support

CLL Support

22,370 members38,481 posts

ASH 2012 Interviews Part 3 Dr. John Byrd on Ibrutinib

bkoffman profile image
bkoffmanCLL CURE Hero
1 Reply

I just posted the third of a four part interview with Dr. Byrd where he discusses some of the details of what we know about ibrutinib therapy so far. This is a deeper look at the complications, combinations, CAR-T and more than in my prior posts so if you are new to the subject I suggest you see the first two parts of the interview with Dr, Byrd and the interviews with Dr. Pagel at the same meeting. They all can be found at bkoffman.blogspot.com

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
1 Reply
jangreen profile image
jangreen

Hi I have watched all the videos with great hope. Enjoy your holiday in Ireland, hope the weather isn't too bad. Best wishes.

You may also like...

ASH 2012 Interview: Dr Jeff Sharman \"Why New CLL Treatments Supersede FCR\"

Patient Power, asks Dr Sharman to discuss whether emerging therapies will replace FCR....

ASH 2012 Ibrutinib Press Conference

http://www.patientpower.info/video/results-suggest-a-potential-breakthrough-in-cll?autoplay=1

ASH 2013: INTERVIEW WITH DR. FURMAN RE: IDELALISIB

last blog post ( http://bkoffman.blogspot.com ), I have a short and interesting video interview...

ASH 2018: Dr. Kipps on antibodies and Venetoclax resistance

work. In the first part of my interview with Dr. Kipps at ASH 2018, he discusses resistance and how...

ASH 2016: Dr. Mato on real world data on ibrutinib

Hi, This week I'm posting an interview that I had with Dr. Anthony Mato from U Penn when we talked...